SAN DIEGO–(BUSINESS WIRE)–Alterome Therapeutics, Inc., a clinical-stage precision oncology company focused on discovering and developing alteration-specific therapeutics to address oncogenic drivers, today announced that members of its management team will participate in the following investor conferences as part of London Life Sciences Week: Jefferies Global Healthcare Conference in London Members of Alterome management team will participate in one-on-one investor meetings Date: November 16-
